2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
12
Stomach Neoplasms
4
Prostatic Neoplasms
4
Polycystic Ovary Syndrome
4
Neoplasms
3
Lung Neoplasms
3
Peripheral Nervous System Diseases
2
Inflammation
2
Esophageal Neoplasms
2
Cardiovascular Diseases
2
Carcinoma, Intraductal, Noninfiltrating
2
Weight Loss
1
Rectal Neoplasms
1
Psychological Well-Being
1
Psoriasis
1
Protein Deficiency
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Pancreatic Neoplasms
1
Pain
1
Ovarian Neoplasms
1
Osteoarthritis
1
Obesity
1
Neoplasm, Residual
1
Multiple Sclerosis
1
Multiple Myeloma
1
Motor Activity
1
Malnutrition
1
Lipid Metabolism Disorders
1
Infections
1
Interventions
telitacicept
3
fludarabine
3
Prednisone
3
Data Collection
3
Cyclophosphamide
3
Specimen Handling
2
Nivolumab
2
Blood Specimen Collection
2
Antilymphocyte Serum
2
thymoglobulin
1
remdesivir
1
prednylidene
1
human papillomavirus vaccine, L1 type 16, 18
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
cabozantinib
1
apremilast
1
Watchful Waiting
1
Vitamin D
1
Valsartan
1
Telemedicine
1
Surveys and Questionnaires
1
Standard of Care
1
Pyridostigmine Bromide
1
Practice Guidelines as Topic
1
Population Groups
1
Platinum Compounds
1
Plasma Exchange
1
Phlebotomy
1
Peripheral Blood Stem Cell Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Autoimmune Diseases
×
Fish Oils
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts